Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew N Phillips

Showing results (21-30 of 287) with videos related to

Pageof 29
Sort By:
Plos One|December 2, 2024
Mathematical modelling to estimate the impact of maternal and perinatal healthcare services and interventions on health in sub-Saharan Africa: A scoping reviewJoseph H Collins, Valentina Cambiano, Andrew N Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2002
Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort studyAntonia L Moore, Caroline A Sabin, Margaret A Johnson, et al.
AIDS (London, England)|September 10, 2003
When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studiesAndrew N Phillips, Alessandro Cozzi Lepri, Fiona Lampe, et al.
AIDS (London, England)|February 26, 2016
Prevalence of recreational drug use is indiscriminate across antiretroviral regimens of differing drug-drug interactions among MSMMarina Daskalopoulou, Alison J Rodger, Andrew N Phillips, et al.
The Journal of Infectious Diseases|March 31, 2010
Antiretroviral drug resistance in HIV-1-infected patients with low-level viremiaNicola E Mackie, Andrew N Phillips, Steve Kaye, et al.
Plos One|March 14, 2015
Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapyRebecca K Lodwick, Fumiyo Nakagawa, Ard van Sighem, et al.
BMJ (Clinical Research Ed.)|January 16, 2007
When should antiretroviral therapy for HIV be started?Andrew N Phillips, Brian G Gazzard, Nathan Clumeck, et al.
BMJ (Clinical Research Ed.)|September 20, 2005
Twenty five years of HIV infection in haemophilic men in Britain: an observational studyCaroline A Sabin, Andrew N Phillips, Thynn Thynn Yee, et al.
AIDS (London, England)|December 31, 2010
Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settingsAndrew N Phillips, Deenan Pillay, Geoff Garnett, et al.
AIDS (London, England)|February 27, 2016
Socioeconomic status and response to antiretroviral therapy in high-income countries: a literature reviewLisa S Burch, Colette J Smith, Andrew N Phillips, et al.
Pageof 29

Showing results (21-30 of 287) with videos related to

Sort By:
Pageof 29
Plos One|December 2, 2024
Mathematical modelling to estimate the impact of maternal and perinatal healthcare services and interventions on health in sub-Saharan Africa: A scoping reviewJoseph H Collins, Valentina Cambiano, Andrew N Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2002
Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort studyAntonia L Moore, Caroline A Sabin, Margaret A Johnson, et al.
AIDS (London, England)|September 10, 2003
When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studiesAndrew N Phillips, Alessandro Cozzi Lepri, Fiona Lampe, et al.
AIDS (London, England)|February 26, 2016
Prevalence of recreational drug use is indiscriminate across antiretroviral regimens of differing drug-drug interactions among MSMMarina Daskalopoulou, Alison J Rodger, Andrew N Phillips, et al.
The Journal of Infectious Diseases|March 31, 2010
Antiretroviral drug resistance in HIV-1-infected patients with low-level viremiaNicola E Mackie, Andrew N Phillips, Steve Kaye, et al.
Plos One|March 14, 2015
Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapyRebecca K Lodwick, Fumiyo Nakagawa, Ard van Sighem, et al.
BMJ (Clinical Research Ed.)|January 16, 2007
When should antiretroviral therapy for HIV be started?Andrew N Phillips, Brian G Gazzard, Nathan Clumeck, et al.
BMJ (Clinical Research Ed.)|September 20, 2005
Twenty five years of HIV infection in haemophilic men in Britain: an observational studyCaroline A Sabin, Andrew N Phillips, Thynn Thynn Yee, et al.
AIDS (London, England)|December 31, 2010
Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settingsAndrew N Phillips, Deenan Pillay, Geoff Garnett, et al.
AIDS (London, England)|February 27, 2016
Socioeconomic status and response to antiretroviral therapy in high-income countries: a literature reviewLisa S Burch, Colette J Smith, Andrew N Phillips, et al.
Pageof 29